These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 1984054

  • 1. Identification of membrane anchorage domains of the HIV-1 gp160 envelope glycoprotein precursor.
    Gabuzda D, Olshevsky U, Bertani P, Haseltine WA, Sodroski J.
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):34-40. PubMed ID: 1984054
    [Abstract] [Full Text] [Related]

  • 2. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU, Vincent MJ, Jabbar MA.
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [Abstract] [Full Text] [Related]

  • 3. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
    Ashorn P, Berger EA, Moss B.
    Methods Enzymol; 1993 Oct; 221():12-8. PubMed ID: 8361369
    [No Abstract] [Full Text] [Related]

  • 4. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
    Fenouillet E, Jones I, Powell B, Schmitt D, Kieny MP, Gluckman JC.
    J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
    [Abstract] [Full Text] [Related]

  • 5. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
    Fenouillet E, Jones IM.
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
    [Abstract] [Full Text] [Related]

  • 6. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
    Guo HG, Veronese FM, Tschachler E, Pal R, Kalyanaraman VS, Gallo RC, Reitz MS.
    Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
    [Abstract] [Full Text] [Related]

  • 7. The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated.
    Yang C, Spies CP, Compans RW.
    Proc Natl Acad Sci U S A; 1995 Oct 10; 92(21):9871-5. PubMed ID: 7568235
    [Abstract] [Full Text] [Related]

  • 8. Computer analysis of human immunodeficiency virus-1 envelope glycoprotein: functional topogenic domains as signals for transfer and cleavage.
    Becker Y.
    Virus Genes; 1991 Oct 10; 5(4):287-312. PubMed ID: 1796551
    [Abstract] [Full Text] [Related]

  • 9. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
    Freed EO, Martin MA.
    J Virol; 1996 Jan 10; 70(1):341-51. PubMed ID: 8523546
    [Abstract] [Full Text] [Related]

  • 10. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure.
    Poumbourios P, el Ahmar W, McPhee DA, Kemp BE.
    J Virol; 1995 Feb 10; 69(2):1209-18. PubMed ID: 7815497
    [Abstract] [Full Text] [Related]

  • 11. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
    Rodriguez D, Rodriguez JR, Esteban M.
    AIDS Res Hum Retroviruses; 1995 Jan 10; 11(1):81-5. PubMed ID: 7734199
    [Abstract] [Full Text] [Related]

  • 12. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein.
    Weiss CD, White JM.
    J Virol; 1993 Dec 10; 67(12):7060-6. PubMed ID: 8230430
    [Abstract] [Full Text] [Related]

  • 13. Human immunodeficiency virus type 1 and 2 envelope glycoproteins oligomerize through conserved sequences.
    Center RJ, Kemp BE, Poumbourios P.
    J Virol; 1997 Jul 10; 71(7):5706-11. PubMed ID: 9188654
    [Abstract] [Full Text] [Related]

  • 14. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    Thali M, Furman C, Helseth E, Repke H, Sodroski J.
    J Virol; 1992 Sep 10; 66(9):5516-24. PubMed ID: 1501286
    [Abstract] [Full Text] [Related]

  • 15. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E, Miquelis R, Drillien R.
    Virology; 1996 Apr 01; 218(1):224-31. PubMed ID: 8615025
    [Abstract] [Full Text] [Related]

  • 16. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
    Bird C, Gleeson PA, Ramsay A, Li P, McCluskey J.
    AIDS Res Hum Retroviruses; 1992 Dec 01; 8(12):1999-2009. PubMed ID: 1493050
    [Abstract] [Full Text] [Related]

  • 17. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y, Tian H, Lane HC, Cohen DI.
    J Immunol; 1993 Dec 15; 151(12):7337-48. PubMed ID: 7903106
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.